# EDGAR Filing Document

**Accession Number:** 0001590144
**File Stem:** 0001590144-25-000007
**Filing Date:** 2025-8
**Character Count:** 4231
**Document Hash:** a86fbf337c8666b69cc00bc8d9fc555d
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001590144-25-000007.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001590144-25-000007

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** PURA VIDA INVESTMENTS, LLC
- **CENTRAL INDEX KEY:** 0001590144

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-16667
- **FILM NUMBER:** 251280582

**BUSINESS ADDRESS:**
- **STREET 1:** 545 W 25TH ST
- **STREET 2:** 19TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10001
- **BUSINESS PHONE:** 646-597-6995

**MAIL ADDRESS:**
- **STREET 1:** 545 W 25TH ST
- **STREET 2:** 19TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10001

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001590144

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** PURA VIDA INVESTMENTS, LLC

**Address:** 545 W 25TH ST, NEW YORK, NY 10001

**Telephone number:** 415-271-4271

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-16667

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                   | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                        | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| ESTABLISHMENT LABS HOLDINGS INC. | G31249108 | 05/23/2025     | To approve, on an advisory basis, the compensation of our named executive officers;                                                     | SECTION 14A SAY-ON-PAY VOTES |          45000 |                0 | ABSTAIN     |                                    45000 | AGAINST                     |  |
| NATERA, INC.                     | 632307104 | 06/12/2025     | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers, as disclosed in this proxy statement. | SECTION 14A SAY-ON-PAY VOTES |           2500 |                0 | ABSTAIN     |                                     2500 | AGAINST                     |  |
| ONCOCYTE Corporation             | 68235C206 | 06/27/2025     | To approve, on a non-binding advisory basis, Oncocyte's named executive officer compensation for the year ended December 31, 2024       | SECTION 14A SAY-ON-PAY VOTES |         285733 |                0 | ABSTAIN     |                                   285733 | AGAINST                     |  |

## N-PX: Signature Block

**Reporting Person:** PURA VIDA INVESTMENTS, LLC

**By (Signature):** Pierre Zamorano

**By (Printed Signature):** Pierre Zamorano

**By (Title):** Chief Compliance Officer and Chief Financial Officer

**Date:** 08/29/2025